Janus Magnetic‐Plasmonic Nanoparticles for Magnetically Guided and Thermally Activated Cancer Therapy

Authors:
Publisher website
Google Scholar
Abstract
Progress of thermal tumor therapies and their translation into clinical practice are limited by insufficient nanoparticle concentration to release therapeutic heating at the tumor site after systemic administration. Herein, the use of Janus magneto‐plasmonic nanoparticles, made of gold nanostars and iron oxide nanospheres, as efficient therapeutic nanoheaters whose on‐site delivery can be improved by magnetic targeting, is proposed. Single and combined magneto‐ and photo‐thermal heating properties of Janus nanoparticles render them as compelling heating elements, depending on the nanoparticle dose, magnetic lobe size, and milieu conditions. In cancer cells, a much more effective effect is observed for photothermia compared to magnetic hyperthermia, while combination of the two modalities into a magneto‐photothermal treatment results in a synergistic cytotoxic effect in vitro. The high potential of the Janus nanoparticles for magnetic guiding confirms them to be excellent nanostructures for in vivo magnetically enhanced photothermal therapy, leading to efficient tumor growth inhibition.
Funding Information
  • European Commission (FP7‐PEOPLE‐2013‐740 IEF‐62647, H2020‐MSCA‐799393, NANOBIOME)
  • Comunidad de Madrid (2018‐T1/IND‐1005, 2018/NMT‐4321, 2018‐T1/IND‐10360)
  • Ministerio de Economía y Competitividad (SEV‐2016‐0686, MAT2017‐86659‐R)
  • Fundación Científica Asociación Española Contra el Cáncer
  • Agencia Estatal de Investigación (MDM‐2017‐0720)
  • Agencia Estatal de Investigación (MDM‐2017‐0720)

This publication has 97 references indexed in Scilit: